| Inflammatory bowel disease and mutations affecting the interleukin-10 receptor EO Glocker, D Kotlarz, K Boztug, EM Gertz, AA Schäffer, F Noyan, M Perro, ... New England Journal of Medicine 361 (21), 2033-2045, 2009 | 1125 | 2009 |
| Stem-cell gene therapy for the Wiskott–Aldrich syndrome K Boztug, M Schmidt, A Schwarzer, PP Banerjee, IA Díez, RA Dewey, ... New England Journal of Medicine 363 (20), 1918-1927, 2010 | 483 | 2010 |
| HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease) C Klein, M Grudzien, G Appaswamy, M Germeshausen, I Sandrock, ... Nature genetics 39 (1), 86, 2007 | 438 | 2007 |
| Gene therapy for Wiskott-Aldrich syndrome—long-term efficacy and genotoxicity CJ Braun, K Boztug, A Paruzynski, M Witzel, A Schwarzer, M Rothe, ... Science translational medicine 6 (227), 227ra33-227ra33, 2014 | 347 | 2014 |
| Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy D Kotlarz, R Beier, D Murugan, J Diestelhorst, O Jensen, K Boztug, ... Gastroenterology 143 (2), 347-355, 2012 | 312 | 2012 |
| A syndrome with congenital neutropenia and mutations in G6PC3 K Boztug, G Appaswamy, A Ashikov, AA Schäffer, U Salzer, J Diestelhorst, ... New England Journal of Medicine 360 (1), 32-43, 2009 | 262 | 2009 |
| Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro VC Asensio, J Maier, R Milner, K Boztug, C Kincaid, M Moulard, ... Journal of virology 75 (15), 7067-7077, 2001 | 130 | 2001 |
| Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27 E Salzer, S Daschkey, S Choo, M Gombert, E Santos-Valente, S Ginzel, ... Haematologica 98 (3), 473-478, 2013 | 128 | 2013 |
| Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies CS Ma, N Wong, G Rao, DT Avery, J Torpy, T Hambridge, J Bustamante, ... Journal of Allergy and Clinical Immunology 136 (4), 993-1006. e1, 2015 | 97 | 2015 |
| Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2 J Jung, G Bohn, A Allroth, K Boztug, G Brandes, I Sandrock, AA Schäffer, ... Blood 108 (1), 362-369, 2006 | 97 | 2006 |
| Early-onset inflammatory bowel disease and common variable immunodeficiency–like disease caused by IL-21 deficiency E Salzer, A Kansu, H Sic, P Májek, A Ikincioğullari, FE Dogu, ... Journal of Allergy and Clinical Immunology 133 (6), 1651-1659. e12, 2014 | 89 | 2014 |
| Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10 K Boztug, MJ Carson, N Pham-Mitchell, VC Asensio, J DeMartino, ... The Journal of Immunology 169 (3), 1505-1515, 2002 | 86 | 2002 |
| B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ E Salzer, E Santos-Valente, S Klaver, SA Ban, W Emminger, ... Blood 121 (16), 3112-3116, 2013 | 85 | 2013 |
| Novel mutations in TNFRSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency OK Alkhairy, R Perez-Becker, GJ Driessen, H Abolhassani, ... Journal of Allergy and Clinical Immunology 136 (3), 703-712. e10, 2015 | 81 | 2015 |
| Inherited DOCK2 deficiency in patients with early-onset invasive infections K Dobbs, C Domínguez Conde, SY Zhang, S Parolini, M Audry, J Chou, ... New England Journal of Medicine 372 (25), 2409-2422, 2015 | 81 | 2015 |
| Development of novel efficient SIN vectors with improved safety features for Wiskott–Aldrich syndrome stem cell based gene therapy I Avedillo Díez, D Zychlinski, EG Coci, M Galla, U Modlich, RA Dewey, ... Molecular pharmaceutics 8 (5), 1525-1537, 2011 | 78 | 2011 |
| JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia K Boztug, PM Järvinen, E Salzer, T Racek, S Mönch, W Garncarz, ... Nature genetics 46 (9), 1021, 2014 | 72 | 2014 |
| Interleukin-2-inducible T-cell kinase (ITK) deficiency-clinical and molecular aspects S Ghosh, K Bienemann, K Boztug, A Borkhardt Journal of clinical immunology 34 (8), 892-899, 2014 | 67 | 2014 |
| Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity KL Willmann, S Klaver, F Doğu, E Santos-Valente, W Garncarz, I Bilic, ... Nature communications 5, 5360, 2014 | 66 | 2014 |
| G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction BH Hayee, A Antonopoulos, EJ Murphy, FZ Rahman, G Sewell, BN Smith, ... Glycobiology 21 (7), 914-924, 2011 | 62 | 2011 |
